Clinical Trial Update: Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a sirolimus-tacrolimus combination following HLA-matched related peripheral blood stem cell transplantation has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Prograf (Tacrolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: The Korean Society of Blood and Marrow Transplantation | Conditions: Acute Leukemia in Remission, Myelodysplastic Syndromes | Phase 2 | Status: TERMINATED